Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 3, 2007 - Issue 3
Submit an article Journal homepage
306
Views
6
CrossRef citations to date
0
Altmetric
Review

Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy

Shimon Lecht1 Department of Pharmacology and Experimental TherapeuticsJerusalem, Israel;3 This manuscript is a part of PhD thesis to be submitted to The Hebrew University of Jerusalem by SL;4 These authors contributed equally in preparation of this manuscript
,
Simon Haroutiunian2 Department of Pharmaceutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of JerusalemJerusalem, Israel;4 These authors contributed equally in preparation of this manuscript
,
Amnon Hoffman2 Department of Pharmaceutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of JerusalemJerusalem, Israel
&
Philip Lazarovici1 Department of Pharmacology and Experimental TherapeuticsJerusalem, IsraelCorrespondence[email protected]
Pages 467-474 | Published online: 28 Dec 2022

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Nikhil R. Bali, Mahesh P. Shinde, Shahadev B. Rathod & Pramod S. Salve. (2021) Enhanced transdermal permeation of rasagiline mesylate nanoparticles: design, optimization, and effect of binary combinations of solvent systems across biological membrane. International Journal of Polymeric Materials and Polymeric Biomaterials 70:3, pages 158-173.
Read now
Ying Chang, Li-Bo Wang, Dan Li, Ke Lei & Song-Yan Liu. (2017) Efficacy of rasagiline for the treatment of Parkinson’s disease: an updated meta-analysis. Annals of Medicine 49:5, pages 421-434.
Read now
Carla Schettino, Clemente Dato, Guglielmo Capaldo, Simone Sampaolo, Giuseppe Di Iorio & Mariarosa AB Melone. (2016) Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study. Neuropsychiatric Disease and Treatment 12, pages 2497-2502.
Read now
Yu Lin, Yanye Zou, Jialiang Lin, Tao Zhang & Jie Deng. (2013) Comparative single-dose pharmacokinetics of rasagiline in minipigs after oral dosing or transdermal administration via a newly developed patch. Xenobiotica 43:8, pages 705-710.
Read now
François Viallet, Séverine Pitel, Sylvie Lancrenon & Olivier Blin. (2013) Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson’s disease. Current Medical Research and Opinion 29:1, pages 23-31.
Read now
Garry M Walsh. (2007) Editorial. Therapeutics and Clinical Risk Management 3:3, pages 361-362.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.